Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
364 studies found for:    shingles
Show Display Options
Download search resultsDownload the search results for:
shingles (364 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly
Condition: Shingles
Intervention: Biological: ZOSTAVAX
2 Recruiting Optimal Timing of Zoster Vaccine After Zoster Illness
Condition: Shingles
Intervention: Biological: Zostavax
3 Completed Shingles Prevention Study
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine;   Biological: Placebo
4 Completed Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Condition: Herpes Zoster Disease
Intervention: Other: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
5 Recruiting Immune Response to Shingles Vaccination
Condition: Shingles
Intervention: Drug: Zoster Vaccine Live
6 Completed Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
Condition: Shingles
Interventions: Biological: zoster vaccine live (Oka/Merck);   Biological: Comparator: placebo (unspecified)
7 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
8 Completed
Has Results
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
Conditions: Herpes Zoster;   Varicella-zoster Vaccine
Intervention: Biological: Zoster Vaccine, Live
9 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
10 Active, not recruiting ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: ZOSTAVAX™
11 Completed A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
12 Active, not recruiting Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
13 Recruiting Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
14 Unknown  T Cell Responses to Varicella Zoster Virus (VZV)
Condition: Immune Response to Zoster Vaccine
Intervention: Biological: Zostavax™
15 Recruiting A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
16 Active, not recruiting Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Conditions: Immunosenescence;   Shingles
Intervention: Biological: Varicella Zoster Virus Vaccine (Zostavax)
17 Completed
Has Results
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Condition: Herpes Zoster
Interventions: Biological: zoster vaccine live (ZOSTAVAX™);   Biological: Comparator: Placebo
18 Completed
Has Results
A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Condition: Herpes Zoster
Interventions: Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation;   Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulation
19 Active, not recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo
20 Active, not recruiting Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine
Condition: Healthy
Intervention: Biological: Live-attenuated varicella-zoster virus vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.